Baidu
map

美国立卫生研究院放弃艾滋病研究资助配额

2016-03-01 徐徐 中国科学报

过去20多年,美国国立卫生研究院(NIH)一直将艾滋病研究资助固定在整体预算的10%。不过,今年NIH将降低这一资助水平。最新公布的基金资助成功率数据反映了放弃该保留配额的一个动机:在很多机构,获得艾滋病研究基金要比非艾滋病研究资助容易很多,而这表明政府官员正在千方百计地寻找花掉这笔钱的办法。 上世纪90年代初,当艾滋病疫情仍处在暴发阶段时,美国国会和NIH同意每年将NIH预算中专门用于艾滋病研

过去20多年,美国国立卫生研究院(NIH)一直将艾滋病研究资助固定在整体预算的10%。不过,今年NIH将降低这一资助水平。最新公布的基金资助成功率数据反映了放弃该保留配额的一个动机:在很多机构,获得艾滋病研究基金要比非艾滋病研究资助容易很多,而这表明政府官员正在千方百计地寻找花掉这笔钱的办法。

上世纪90年代初,当艾滋病疫情仍处在暴发阶段时,美国国会和NIH同意每年将NIH预算中专门用于艾滋病研究的部分稳定在10%左右。然而,自此以后,一些机构费尽心思寻找花掉艾滋病拨款的办法,有时甚至会扩展艾滋病研究的定义,或者放松标准。最近,一些国会议员就此提出了质疑:当美国的艾滋病死亡人数已开始下降时,为这种疾病提供的特殊待遇是否仍有意义?

去年,NIH院长Francis Collins宣布,该机构将把艾滋病资助更加直接地转向聚焦疫苗和治疗方法。12月,征得国会同意后,NIH正式放弃10%的资助配额。

该结果从NIH的2017财年预算请求中可见一斑。今年,该机构对艾滋病研究的资助金额同2015年的30亿美元持平,并且有望在2017年保持这一水平。由于NIH去年的预算增长了近7%并且正要求进一步增加明年的预算,因此分配给艾滋病研究的部分将从2015年的10%下降到今年的9.3%,明年则可能降至9%。

Collins表示,今年该机构还从快到期的艾滋病研究基金中拿出1.54亿美元用于新的重点研究任务。接下来的几年,NIH希望每年再转移6000万~7000万美元。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
    2017-09-11 1861ff86b0m

    是翻译有问题还是

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
    2016-03-05 wei834766788

    不太明白

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
    2016-03-02 1de07360m07(暂无匿称)

    了解下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
    2016-03-01 破风4392

    !!!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
    2016-03-01 破风4392

    力挺

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
    2016-03-01 忠诚向上

    啥情况

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=242900, encodeId=0da1242900d7, content=是翻译有问题还是, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c6c2144166, createdName=1861ff86b0m, createdTime=Mon Sep 11 14:57:47 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811134, encodeId=89ad181113403, content=<a href='/topic/show?id=67868683032' target=_blank style='color:#2F92EE;'>#艾滋病研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86830, encryptionId=67868683032, topicName=艾滋病研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Wed Aug 17 18:01:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018414, encodeId=1be6201841490, content=<a href='/topic/show?id=ba9f41030fe' target=_blank style='color:#2F92EE;'>#国立卫生研究院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41030, encryptionId=ba9f41030fe, topicName=国立卫生研究院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Fri Feb 10 17:01:00 CST 2017, time=2017-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67406, encodeId=dc256e406e6, content=不太明白, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sat Mar 05 21:33:00 CST 2016, time=2016-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66725, encodeId=c73b66e250c, content=了解下, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bd31668701, createdName=1de07360m07(暂无匿称), createdTime=Wed Mar 02 03:46:00 CST 2016, time=2016-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66573, encodeId=8edd665e3b0, content=!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 15:17:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66512, encodeId=5a666651236, content=力挺, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160301/IMG56D53216887587291.jpg, createdBy=3c131694128, createdName=破风4392, createdTime=Tue Mar 01 14:12:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66481, encodeId=af0a66481ed, content=啥情况, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66482, encodeId=b88266482f7, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Mar 01 12:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=)]
    2016-03-01 忠诚向上

    支持

    0

相关资讯

HIV蛋白控制数以百计基因用以促进艾滋病发展

德克萨斯大学西南医学中心的研究人员破解了一种由HIV制成的小蛋白质如何引起艾滋病并操纵人类基因最终致命的过程。 “我们已经鉴定了蛋白质分子机制,由艾滋病毒与宿主细胞相互作用形成的Tat蛋白能激活或抑制数百种人类基因,” Iván D'Orso博士说, “调查结果清楚地表明,阻止Tat蛋白活性可能对艾滋病患者的治疗有一定价值。” 我们早就知道,艾滋病病毒会引发艾滋病抑制人体免疫细胞发展,并将

世界艾滋病日:带来治愈希望的新技术

为提高人们对艾滋病的认识,世界卫生组织于1988年将每年的12月1日定为世界艾滋病日,号召世界各国和国际组织在这一天举办相关活动,宣传和普及预防艾滋病的知识。从2011年开始,世界艾滋病日的主题都一直是Getting to Zero——零感染,零歧视和零死亡。而今年,联合国会员国也提出了更新应对艾滋病的目标,即在2030年前结束艾滋病流行。 这也就是说“结束艾滋病”已经被提上了日程,虽然我们身

NEJM:艾滋病患者接受ART后10年生存率能达七成

我们报道了一项关于艾滋病患者接受连续抗逆转录病毒治疗(ART)后10年生存率的队列研究,该研究来自海地太子港,纳入自2003至2004年间入院接受ART、且年龄大等于13岁的患者共910例,随访时间为10年;ART与随访期间护理均严格按照世界卫生组织(WHO)指南。该回顾性队列研究的有关细节已有报道,已获得有关机构审查委员会伦理学批准。死亡事件可从医疗记录中确定。转院患者资料在转院时审查。将随访终

2015年关于HIV/AIDS的10大事实

尽管目前对HIV/AIDS的认识等有重大进展,但是HIV/AIDS依旧是全球范围内重大公共卫生挑战,尤其是低中收入国家;撒哈拉以南非洲女性风险尤其高。自1984年起,每年的12月1日作为世界艾滋病日,这一天将举办各种宣传和普及预防艾滋病的知识有关活动,意在团结大众抵抗HIV,支持HIV感染人群,纪念已故人群。9月联合国成员达成一致协议:将于2030年终结AIDS的流行。虽然目标宏伟,但根据WHO、

世卫组织:关于艾滋病/HIV的实况报道

重要事实HIV依然是威胁全球人类健康的一大问题,到目前为止HIV已剥夺了3400多万人的性命。2014年,全球范围内HIV相关原因所致的死亡人数达120万。至2014年底,全球的HIV病毒感染者将近有3690万;2014年,全球范围内HIV新感染患者达200万。撒哈拉以南非洲是HIV感染最严重的地区,2014年该地区有2580万HIV病毒感染者;此外,全球所有的HIV新感染患者,有将近70%来

疾控中心:艾滋病常见问题解答

艾滋病毒是如何传播的?艾滋病毒可通过与感染者发生未保护的性交(阴道交或肛交)和口交;输入受艾滋病毒污染的血液;共用受艾滋病毒污染的针头、针具或其他锐器等途径传播。还可通过受艾滋病毒感染的母亲在妊娠、分娩和哺乳期间传播给婴儿。艾滋病毒感染者多长时间发展为艾滋病患者?由艾滋病毒感染者发展为艾滋病患者的时间存在很大的个体差异。如果没有获得相应的治疗,大部分艾滋病毒感染者在感染后5-10年内出现艾滋病毒相

Baidu
map
Baidu
map
Baidu
map